FHTX — Foghorn Therapeutics Share News
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m
Foghorn Therapeutics rises as FDA lifts clinical hold on cancer drug trial
U.S. STOCKS ON THE MOVE-Foghorn Therapeutics, Novavax, Apple
Foghorn Therapeutics jumps as FDA lifts clinical hold on cancer drug trial
Brief: Foghorn Therapeutics Says FDA Has Lifted Clinical Hold On Phase 1 Study Of FHD-286
Brief: Foghorn Therapeutics Provides Q1 2023 Financial And Corporate Update
Brief: Foghorn Therapeutics Q1 EPS USD -0.73
U.S. RESEARCH ROUNDUP- Booking Holdings, Coca-Cola, Zebra Technologies
U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, Foghorn Therapeutics, Bluebird Bio
Foghorn Therapeutics falls on pausing enrollment in cancer study
Foghorn Therapeutics pauses enrollment in cancer drug study (updated)
Brief: Foghorn Therapeutics Provides Update On FHD-609
Foghorn Therapeutics pauses enrollment in cancer study
U.S. RESEARCH ROUNDUP- Ameresco, Bioxcel Therapeutics, Roblox
Brief: Foghorn Therapeutics Provides 2023 Outlook And Full Year 2022 Corporate Update
Brief: Foghorn Therapeutics Securities Provides Significant Cash Runway Into H2 2025
Brief: Foghorn Therapeutics Provides Third Quarter Financial Results
Brief: Foghorn Therapeutics Announces New Data Demonstrating Brd9 Degradation In Patient Tumor Biopsies And Discloses New Selective Cbp Program
U.S. STOCKS ON THE MOVE-Macy, Tritium, Ares Management
U.S. STOCKS ON THE MOVE-Energy firms, Natgas companies, ProPetro